Inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B)
Overview
Authors
Affiliations
Recent studies have demonstrated that protein tyrosine phosphatase 1B (PTP1B) is involved in the down regulation of insulin signaling. Selective inhibitors of PTP1B hold much promise for the treatment of type 2 diabetes mellitus and obesity. Consequently much effort, by both industry and academia, has been devoted towards the development of PTP1B specific inhibitors. This article gives an overview of reports that have appeared in the primary scientific literature on the development of PTP1B inhibitors, starting from the days of early development up to September of 2002.
Kazakova O, Giniyatullina G, Babkov D, Wimmer Z Int J Mol Sci. 2022; 23(3).
PMID: 35162998 PMC: 8834734. DOI: 10.3390/ijms23031075.
Jiang C, Liang L, Guo Y Acta Pharmacol Sin. 2012; 33(10):1217-45.
PMID: 22941286 PMC: 4002712. DOI: 10.1038/aps.2012.90.
Zhao L, Wang Z, Ruan Y, Zhou W Mol Cell Biochem. 2012; 366(1-2):149-57.
PMID: 22476902 DOI: 10.1007/s11010-012-1292-0.
Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop A, Zhang X, Lone A Methods. 2007; 42(3):278-88.
PMID: 17532515 PMC: 1950444. DOI: 10.1016/j.ymeth.2007.02.005.